Histiocytic Disorders, Malignant
"Histiocytic Disorders, Malignant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Distinctive neoplastic disorders of histiocytes. Included are malignant neoplasms of MACROPHAGES and DENDRITIC CELLS.
| Descriptor ID |
D015620
|
| MeSH Number(s) |
C04.557.227 C15.604.250.390
|
| Concept/Terms |
Histiocytic Disorders, Malignant- Histiocytic Disorders, Malignant
- Disorder, Malignant Histiocytic
- Disorders, Malignant Histiocytic
- Histiocytic Disorder, Malignant
- Malignant Histiocytic Disorder
- Malignant Histiocytic Disorders
|
Below are MeSH descriptors whose meaning is more general than "Histiocytic Disorders, Malignant".
Below are MeSH descriptors whose meaning is more specific than "Histiocytic Disorders, Malignant".
This graph shows the total number of publications written about "Histiocytic Disorders, Malignant" by people in this website by year, and whether "Histiocytic Disorders, Malignant" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Histiocytic Disorders, Malignant" by people in Profiles.
-
Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Acute Lymphoblastic Leukemias, Mixed-Phenotype Acute Leukemias, Myeloid/Lymphoid Neoplasms With Eosinophilia, Dendritic/Histiocytic Neoplasms, and Genetic Tumor Syndromes. Mod Pathol. 2024 May; 37(5):100466.
-
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016 06 02; 127(22):2672-81.
-
A broad survey of cathepsin K immunoreactivity in human neoplasms. Am J Clin Pathol. 2013 Feb; 139(2):151-9.
-
Early development of histiocytic sarcomas in p53 knockout mice treated with N-bis(2-hydroxypropyl)nitrosamine. Oncol Rep. 2007 Oct; 18(4):755-61.
-
The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans. Cancer Cell. 2006 May; 9(5):379-90.
-
Targeting of transgene expression to monocytes by cytochrome b heavy chain gene 5'-flanking sequences induces histiocytic malignancies. Trans Assoc Am Physicians. 1990; 103:129-36.